Date published: 2026-4-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

γPAK Activators

γPAK activators constitute a diverse group of small molecules, each playing a distinctive role in interacting with a network of proteins to promote the activation of γPAK. These activators demonstrate chemical diversity and interact with upstream regulators, particularly Rho GTPases such as Cdc42 and Rac1, which are pivotal in governing γPAK activity. The modulation of these GTPases is a key strategy employed by certain activators, exemplified by compounds like ZCL278 and NSC23766. These molecules function by modifying the interaction between GTPases and their regulatory proteins, maintaining the GTP-bound active state of these enzymes, and thereby facilitating the activation of γPAK. The ultimate influence on γPAK is achieved through the delicate modulation of the intrinsic balance of signaling networks, often involving targeted inhibition or modification of specific proteins within these networks.

Furthermore, certain compounds such as LY294002, PF-562271, and Fasudil showcase an indirect mechanism of γPAK activation. Inhibiting specific kinases or proteins triggers compensatory cellular mechanisms that lead to the activation of γPAK. For instance, inhibition of FAK or GSK-3 can induce signaling alterations that enhance the activity of upstream regulators Rac1 and Cdc42, indirectly promoting γPAK activation. Additionally, the complex interplay of cellular feedback and cross-talk between signaling pathways is evident in scenarios where inhibition of one component, as seen with the Arp2/3 complex using CK-666, results in the activation of γPAK through indirect routes. These small molecule activators collectively serve as invaluable tools in unraveling the intricate regulatory environment of γPAK activation. They provide a nuanced understanding of the broader cellular context in which γPAK operates, shedding light on the complex interconnections between signaling pathways and the compensatory mechanisms cells employ to maintain homeostasis. The diverse strategies employed by these activators underscore the multifaceted nature of γPAK regulation, offering insights into research associated with dysregulated γPAK activity.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

ZCL278

587841-73-4sc-507369
10 mg
$115.00
(0)

ZCL278 is a small molecule that directly binds to Cdc42, displacing its GTPase-activating proteins (GAPs) and leading to its persistent activation, which in turn actively engages γPAK in signaling pathways.

EHop-016

1380432-32-5sc-497382
5 mg
$80.00
(0)

EHop-016 acts as a Rac1 inhibitor by binding to Vav2, preventing Rac1 activation. However, its binding can paradoxically lead to increased Rac1-GTP levels in certain contexts, indirectly facilitating γPAK activation.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

Although primarily a PI3K inhibitor, LY294002 can indirectly influence γPAK activity through complex feedback loops within the PI3K/Akt pathway that can modulate Rac1 and Cdc42 activity.

PF-562271

717907-75-0sc-478488
sc-478488A
sc-478488B
5 mg
10 mg
50 mg
$312.00
$474.00
$1124.00
3
(1)

PF-562271 is a focal adhesion kinase (FAK) inhibitor which can lead to compensatory activation of Rac1/Cdc42 and subsequent γPAK activation as part of cellular adhesion and migration signaling.

GSK-3 Inhibitor IX

667463-62-9sc-202634
sc-202634A
sc-202634B
1 mg
10 mg
50 mg
$58.00
$188.00
$884.00
10
(1)

This inhibitor suppresses GSK-3 activity, which can lead to increased β-catenin signaling; this augmented signaling may enhance Rac1/Cdc42 activity, indirectly activating γPAK.

CK 666

442633-00-3sc-361151
sc-361151A
10 mg
50 mg
$321.00
$1040.00
5
(0)

CK-666 stabilizes the inactive form of the Arp2/3 complex, leading to a negative impact on actin polymerization; this can result in compensatory cellular responses that activate Rac1 and γPAK.

(RS)-3,5-DHPG

19641-83-9sc-205496
sc-205496A
10 mg
50 mg
$152.00
$632.00
(1)

(RS)-3,5-Dihydroxyphenylglycine (DHPG) is a selective agonist for group I metabotropic glutamate receptors which can lead to the activation of intracellular signaling cascades involving Rac1 and PAK activation.